ZVSA

0.00010.00%
AF

Alessia Fornoni

Member of Scientific Advisory Board

Dr. Alessia Fornoni, M.D., Ph.D., FASN, serves as Member of the Clinical Advisory Board at Fibrocor Therapeutics, Inc since December 2025. serves as the Vice-President and Chief Scientific Officer of L&F Health LLC, a small start-up company focused on finding a cure for patients affected by chronic kidney diseases. Dr. Fornoni serves as Professor of Medicine and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine and serves as Director of the Diabetic Nephropathy Clinic and Director of the Peggy and Harold Katz Drug Discovery Center. She is the Chief of the Division of Nephrology and Hypertension. She is Co-Director of Novel Methods for the Clinical and Translational Science Institute (CTSI) and Associate Director of the MD PhD program at the same Institution. Dr. Fornoni has also gained experience in drug development as Global Head of Discovery in Cardiovascular and Metabolism at Hoffman-La Roche in Basel. As a physician-scientist who has maintained a resolutely focused research program that has provided novel and seminal contributions to the understanding of the pathogenesis of kidney disease, she has conducted research supported by grants from National Institutes of Health, industry and private foundations. She has been a Member of Medical Advisory Board of Dimerix Limited since October 17, 2017. She serves as Member of Scientific Advisory Board at ZyVersa Therapeutics, Inc. (formerly known as Variant Pharmaceuticals, Inc.). She has received prestigious awards, serves on the editorial board of Diabetes and other journals, has been invited to present at national and international meetings in five different continents and has served as visiting professor at more than 25 academic institutions. Dr. Fornoni serves as grant reviewer for NIH, DOD, ADA, AHA, UK-diabetes and the Italian Ministry of Health. She is also the Associate Director of the MD PhD program. Her contributions have been published in high impact journals: Journal of Clinical Investigation, NEJM, Nature Medicine, Science Translational Medicine, Journal of Biological Chemistry, Diabetes, Kidney International and the Journal of the American Society of Nephrology among others. Dr. Fornoni received her medical degree from the School of Medicine at the University of Pavia, Italy. She subsequently obtained a Ph.D. Degree in Medical Pharmacology from University of Pavia, Italy.

Positions